132 related articles for article (PubMed ID: 36924652)
41. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
Schetinger MR; Morsch VM; Bonan CD; Wyse AT
Biofactors; 2007; 31(2):77-98. PubMed ID: 18806312
[TBL] [Abstract][Full Text] [Related]
42. Ectonucleotidase inhibitors: a patent review (2011-2016).
Al-Rashida M; Qazi SU; Batool N; Hameed A; Iqbal J
Expert Opin Ther Pat; 2017 Dec; 27(12):1291-1304. PubMed ID: 28870136
[TBL] [Abstract][Full Text] [Related]
43. Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis.
Khan NA; Rashid F; Jadoon MSK; Jalil S; Khan ZA; Orfali R; Perveen S; Al-Taweel A; Iqbal J; Shahzad SA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234774
[TBL] [Abstract][Full Text] [Related]
44. Immunolocalization of ectonucleotidases along the rat nephron.
Vekaria RM; Shirley DG; Sévigny J; Unwin RJ
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F550-60. PubMed ID: 16189292
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, kinetic studies and
Mustafa MN; Channar PA; Sarfraz M; Saeed A; Ejaz SA; Aziz M; Alasmary FA; Alsoqair HY; Raza H; Kim SJ; Hamad A
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2163394. PubMed ID: 36629454
[TBL] [Abstract][Full Text] [Related]
46. Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist.
He W; Wilder T; Cronstein BN
Br J Pharmacol; 2013 Nov; 170(6):1167-76. PubMed ID: 23962057
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.
Lecka J; Rana MS; Sévigny J
Br J Pharmacol; 2010 Nov; 161(5):1150-60. PubMed ID: 20977463
[TBL] [Abstract][Full Text] [Related]
48. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
49. Differential ectonucleotidase expression in human bladder cancer cell lines.
Stella J; Bavaresco L; Braganhol E; Rockenbach L; Farias PF; Wink MR; Azambuja AA; Barrios CH; Morrone FB; Oliveira Battastini AM
Urol Oncol; 2010; 28(3):260-7. PubMed ID: 19372055
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
51. Ecto-nucleotidase inhibitors: recent developments in drug discovery.
Baqi Y
Mini Rev Med Chem; 2015; 15(1):21-33. PubMed ID: 25694081
[TBL] [Abstract][Full Text] [Related]
52. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
[TBL] [Abstract][Full Text] [Related]
53. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
54. An efficient synthetic approach toward a sporadic heterocyclic scaffold: 1,3-Oxathiol-2-ylidenes; alkaline phosphatase inhibition and molecular docking studies.
Saeed A; Khurshid A; Shabir G; Mahmood A; Zaib S; Iqbal J
Bioorg Med Chem Lett; 2020 Jul; 30(13):127238. PubMed ID: 32386855
[TBL] [Abstract][Full Text] [Related]
55. Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5'-Nucleotidase Inhibitors.
Viviani LG; Piccirillo E; Ulrich H; Amaral AT
J Chem Inf Model; 2020 Feb; 60(2):621-630. PubMed ID: 31714079
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, characterization, alkaline phosphatase inhibition assay and molecular modeling studies of 1-benzylidene-2-(4-tert- butylthiazol-2-yl) hydrazines.
Aziz H; Mahmood A; Zaib S; Saeed A; El-Seedi HR; Pelletier J; Sévigny J; Iqbal J
J Biomol Struct Dyn; 2021 Oct; 39(16):6140-6153. PubMed ID: 32779527
[TBL] [Abstract][Full Text] [Related]
57. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, Characterization, and
Ashraf A; Shafiq Z; Khan Jadoon MS; Tahir MN; Pelletier J; Sevigny J; Yaqub M; Iqbal J
ACS Med Chem Lett; 2020 Dec; 11(12):2397-2405. PubMed ID: 33335662
[TBL] [Abstract][Full Text] [Related]
59. Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion.
Lavoie EG; Fausther M; Kauffenstein G; Kukulski F; Künzli BM; Friess H; Sévigny J
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E647-56. PubMed ID: 20682839
[TBL] [Abstract][Full Text] [Related]
60. Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
Cappellari AR; Rockenbach L; Dietrich F; Clarimundo V; Glaser T; Braganhol E; Abujamra AL; Roesler R; Ulrich H; Battastini AM
PLoS One; 2012; 7(10):e47468. PubMed ID: 23094051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
